Document Detail

Plesiomonas shigelloides infection in Hong Kong: retrospective study of 167 laboratory-confirmed cases.
MedLine Citation:
PMID:  11177159     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To study the epidemiological, clinical, and microbiological features of Plesiomonas shigelloides infection in Hong Kong. DESIGN: Retrospective study. SETTING: Infectious Disease Unit of a district hospital, Hong Kong. PATIENTS: Patients with laboratory-confirmed cases of Plesiomonas shigelloides infection between 1 January 1995 and 31 December 1998. MAIN OUTCOME MEASURES: Epidemiological and clinical data, antibiotic sensitivity, and clinical outcome. RESULTS: There was an increasing trend in the number of isolates of Plesiomonas shigelloides obtained and the prevalence of the bacterium. A total of 197 isolates were obtained from 188 patients, and most isolates (172; 87.3%) were obtained during the summer. Clinical and epidemiological data were available for 167 patients (85 males, 82 females). Patient age ranged from 1 month to 95 years; the mean and median ages of the patients older than 15 years were 51.0 and 40.5 years, respectively (n=132). Only 35 (21.0%) of the 167 patients had a history of travel outside Hong Kong, whereas 21 (12.6%) had a history of consuming seafood or uncooked food; 39 (23.4%) had underlying medical conditions. Most patients (165; 98.8%) had symptoms of Plesiomonas shigelloides infection. Nine (5.4%) patients had had chronic diarrhoea for more than 2 weeks; watery and bloody diarrhoea was discharged by 122 (73.1%) and 42 (25.1%) of the patients, respectively. All 197 Plesiomonas shigelloides isolates were sensitive to ofloxacin, or levofloxacin and ceftriaxone. Resistance or partial resistance was recorded for ampicillin (72%), tetracycline (67%), co-trimoxazole (12%), and chloramphenicol (5%). The majority of patients (142/167; 85.0%) had self-limiting cases of infection, but 25 patients were given antibiotics for more severe symptoms at the time of presentation; there were two deaths. CONCLUSIONS: The occurrence of Plesiomonas shigelloides infection in Hong Kong is increasing, although most cases of are self-limiting.
T Y Wong; H Y Tsui; M K So; J Y Lai; S T Lai; C W Tse; T K Ng
Related Documents :
11864279 - Aspergillus species isolated from clinical specimens: suggested clinical and microbiolo...
6977209 - Trimethoprim-sulphamethoxazole in the treatment of enteric fever in the sudan.
9002579 - Psoas abscess: making an early diagnosis in the ed.
11100279 - Fungal colonization and invasive fungal infections following allogeneic bmt using metro...
2739019 - Plasma tumor necrosis factor levels in patients with presumed sepsis. results in those ...
531529 - Urological septicemia. a retrospective study.
18591009 - Fluctuations in tremor and respiration in patients with parkinson's disease.
2913849 - The lumbar epidural space in patients examined with epiduroscopy.
2405179 - Fluid-aided sonography of the stomach and duodenum in the diagnosis of peptic ulcer dis...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Hong Kong medical journal = Xianggang yi xue za zhi / Hong Kong Academy of Medicine     Volume:  6     ISSN:  1024-2708     ISO Abbreviation:  Hong Kong Med J     Publication Date:  2000 Dec 
Date Detail:
Created Date:  2001-02-22     Completed Date:  2001-07-12     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9512509     Medline TA:  Hong Kong Med J     Country:  China    
Other Details:
Languages:  eng     Pagination:  375-80     Citation Subset:  IM    
Department of Medicine and Geriatrics, Princess Margaret Hospital, Laichikok, Kowloon, Hong Kong.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Anti-Bacterial Agents / administration & dosage,  therapeutic use
Child, Preschool
Drug Resistance, Microbial
Gram-Negative Bacterial Infections / drug therapy,  epidemiology*,  microbiology
Hong Kong / epidemiology
Length of Stay
Middle Aged
Plesiomonas* / drug effects
Retrospective Studies
Reg. No./Substance:
0/Anti-Bacterial Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Comparison of two dosages of recombinant human follicle-stimulating hormone in Chinese women undergo...
Next Document:  Evaluation of the benefits and risks of hormone replacement therapy.